Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sarepta Therapeutics (SRPT)
NASDAQ:SRPT
Holding SRPT?
Track your performance easily
Sarepta Therapeutics (SRPT) Ownership Overview
4.08% Insiders
28.53% Mutual Funds
3.59% Other Institutional Investors
20.27% ETFs
43.54% Public Companies and
Individual Investors
The ownership structure of Sarepta Therapeutics (SRPT) stock is a mix of institutional, retail, and individual investors. Approximately 52.38% of the company’s stock is owned by Institutional Investors, 4.08% is owned by Insiders, and 43.54% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Sep 03, 2024 | xxxxxxxxxxxxx | $822100 | |
| Aug 20, 2024 | Michael Andrew Chambers Director | xxxxxxxxxxxxx | $4955728 |
| Mar 11, 2024 | Kathryn Jean Boor Director | xxxxxxxxxxxxx | $93550 |
| Mar 11, 2024 | Hans Lennart Rudolf Wigzell Director | xxxxxxxxxxxxx | $1848795 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $1785558 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $1975316 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $2830728 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $3220198 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,357,214 | Institution | 8.75% | 984,814,098 | |
| 7,815,886 | Institution | 8.18% | 921,024,006 | |
| 6,198,716 | Institution | 6.49% | 730,456,693 | |
| 3,181,688 | Insider | 3.33% | 374,930,114 | |
| 3,008,720 | Institution | 3.15% | 354,547,565 | |
| 2,295,000 | Institution | 2.40% | 270,442,800 | |
| 2,099,199 | Institution | 2.20% | 247,369,610 | |
| 2,088,298 | Institution | 2.19% | 246,085,036 | |
| 1,654,174 | Institution | 1.73% | 194,927,864 | |
| 1,264,046 | Institution | 1.32% | 148,955,181 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,815,886 | Institution | 8.18% | 921,024,006 | |
| 2,099,199 | Institution | 2.20% | 247,369,610 | |
| 2,088,298 | Institution | 2.19% | 246,085,036 | |
| 1,654,174 | Institution | 1.73% | 194,927,864 | |
| 1,264,046 | Institution | 1.32% | 148,955,181 | |
| 988,982 | Institution | 1.04% | 116,541,639 | |
| 943,691 | Institution | 0.99% | 111,204,547 | |
| 894,400 | Institution | 0.94% | 105,396,096 | |
| 493,722 | Institution | 0.52% | 58,180,200 | |
| 480,304 | Institution | 0.50% | 56,599,023 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,854,339 | Institution | 2.99% | 356,478,398 | |
| 3,021,339 | Institution | 3.16% | 356,034,588 | |
| 2,267,946 | Institution | 2.37% | 283,243,776 | |
| 1,526,767 | Institution | 1.60% | 185,670,135 | |
| 1,425,991 | Institution | 1.49% | 178,092,016 | |
| 1,250,592 | Institution | 1.31% | 156,186,435 | |
| 764,066 | Institution | 0.80% | 90,037,537 | |
| 628,487 | Institution | 0.66% | 74,060,908 | |
| 499,147 | Institution | 0.52% | 58,819,482 | |
| 476,345 | Institution | 0.50% | 56,132,495 |
FAQ
Who Owns Sarepta Therapeutics (SRPT)?
According to the latest TipRanks data, approximately 3.59% of the company's stock is held by institutional investors, 4.08% is held by insiders, and 43.54% is held by retail investors.
What percentage of Sarepta Therapeutics (SRPT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 3.59% of Sarepta Therapeutics (SRPT) stock is held by institutional investors.
What percentage of Sarepta Therapeutics (SRPT) stock is held by retail investors?
According to the latest TipRanks data, approximately 43.54% of Sarepta Therapeutics (SRPT) stock is held by retail investors.
Who owns the most shares of Sarepta Therapeutics (SRPT)?
Vanguard owns the most shares of Sarepta Therapeutics (SRPT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.